R1 RCM (NASDAQ:RCM) Shares Gap Up to $12.45

R1 RCM Inc. (NASDAQ:RCM) gapped up prior to trading on Wednesday . The stock had previously closed at $12.45, but opened at $13.20. R1 RCM shares last traded at $13.16, with a volume of 2,070,294 shares trading hands.

Analyst Ratings Changes

Several analysts recently issued reports on the stock. Morgan Stanley reissued an “overweight” rating and issued a $17.00 price target on shares of R1 RCM in a research report on Tuesday, March 26th. Royal Bank of Canada reissued an “outperform” rating and issued a $19.00 price target on shares of R1 RCM in a research report on Thursday, March 7th. SVB Leerink assumed coverage on shares of R1 RCM in a research report on Monday, February 26th. They issued an “outperform” rating and a $14.00 price target for the company. Guggenheim reduced their price target on shares of R1 RCM from $17.00 to $15.00 and set a “buy” rating for the company in a research report on Friday, April 5th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and set a $20.00 price objective on shares of R1 RCM in a report on Wednesday, April 10th. Five investment analysts have rated the stock with a hold rating and eight have given a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $16.71.

R1 RCM Trading Down 4.4 %

The company has a quick ratio of 1.83, a current ratio of 1.83 and a debt-to-equity ratio of 0.57. The stock’s fifty day moving average is $12.84 and its two-hundred day moving average is $11.46.

R1 RCM (NASDAQ:RCM) last released its quarterly earnings data on Wednesday, May 8th. The healthcare provider reported ($0.08) EPS for the quarter, missing the consensus estimate of ($0.05) by ($0.03). The business had revenue of $603.90 million for the quarter, compared to analysts’ expectations of $612.88 million. R1 RCM had a net margin of 0.15% and a return on equity of 0.12%. The firm’s revenue was up 10.7% compared to the same quarter last year. On average, analysts expect that R1 RCM Inc. will post -0.05 EPS for the current year.

Insider Transactions at R1 RCM

In other news, President John M. Sparby sold 10,046 shares of the stock in a transaction dated Thursday, March 7th. The shares were sold at an average price of $14.33, for a total value of $143,959.18. Following the sale, the president now directly owns 265,986 shares of the company’s stock, valued at $3,811,579.38. The sale was disclosed in a legal filing with the SEC, which is available at this link. Insiders own 36.80% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the stock. Retirement Systems of Alabama increased its position in shares of R1 RCM by 0.3% in the first quarter. Retirement Systems of Alabama now owns 247,476 shares of the healthcare provider’s stock worth $3,187,000 after purchasing an additional 856 shares during the last quarter. PNC Financial Services Group Inc. grew its position in R1 RCM by 4.9% during the fourth quarter. PNC Financial Services Group Inc. now owns 19,601 shares of the healthcare provider’s stock valued at $207,000 after acquiring an additional 908 shares during the last quarter. Van ECK Associates Corp lifted its stake in R1 RCM by 20.5% in the fourth quarter. Van ECK Associates Corp now owns 6,141 shares of the healthcare provider’s stock worth $65,000 after acquiring an additional 1,044 shares during the period. State of Michigan Retirement System lifted its stake in R1 RCM by 2.5% in the first quarter. State of Michigan Retirement System now owns 48,401 shares of the healthcare provider’s stock worth $623,000 after acquiring an additional 1,200 shares during the period. Finally, Victory Capital Management Inc. lifted its stake in R1 RCM by 4.2% in the third quarter. Victory Capital Management Inc. now owns 31,275 shares of the healthcare provider’s stock worth $471,000 after acquiring an additional 1,250 shares during the period. 61.10% of the stock is currently owned by institutional investors.

R1 RCM Company Profile

R1 RCM Inc provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers.